Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study.

Vlad RatziuArun SanyalStephen A HarrisonVincent Wai-Sun WongSven FrancqueZachary GoodmanGuruprasad P AithalKris V KowdleyStar SeyedkazemiLaurent FischerRohit LoombaManal F AbdelmalekFrank Tacke

Published in: Hepatology (Baltimore, Md.) (2020)

CVC was well tolerated, and year 2 data corroborate antifibrotic findings from year 1. The majority on CVC who achieved fibrosis response at year 1 maintained it at year 2, with greater effect in advanced fibrosis. ClinicalTrials.gov number, NCT02217475 (CENTAUR).

Keyphrases

liver fibrosis
big data
machine learning
combination therapy
data analysis
artificial intelligence